KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Assets (2019 - 2025)

Vir Biotechnology's Return on Assets history spans 7 years, with the latest figure at 0.43% for Q4 2025.

  • For Q4 2025, Return on Assets fell 7.0% year-over-year to 0.43%; the TTM value through Dec 2025 reached 0.43%, down 7.0%, while the annual FY2025 figure was 0.36%, 5.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.43% at Vir Biotechnology, up from 0.45% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.5% in Q1 2022 and bottomed at 0.45% in Q3 2025.
  • The 5-year median for Return on Assets is 0.19% (2023), against an average of 0.09%.
  • The largest annual shift saw Return on Assets skyrocketed 58bps in 2022 before it crashed -71bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.33% in 2021, then tumbled by -44bps to 0.19% in 2022, then crashed by -265bps to 0.31% in 2023, then decreased by -16bps to 0.36% in 2024, then decreased by -20bps to 0.43% in 2025.
  • Per Business Quant, the three most recent readings for VIR's Return on Assets are 0.43% (Q4 2025), 0.45% (Q3 2025), and 0.44% (Q2 2025).